Literature DB >> 10318719

Diffusion MR imaging. Theory and applications.

H A Rowley1, P E Grant, T P Roberts.   

Abstract

Diffusion MR imaging provides a novel way to characterize tissues based on sensitivity to the microscope molecular motion of water. Clinical implementation requires strong, fast hardware and careful post-processing of diffusion parameters. It is important to recognize that diffusion images and derivatives such as the trace of the diffusion tensor are quite specific in reflecting the physical properties of diffusion, but are non-specific for pathology. Restricted diffusion is the earliest clinically detectable sign of ischemia, but similar diffusion changes can be seen with infection and some tumors. Diffusion MR techniques are providing new ways to study problems in oncology, epilepsy, white matter disorders, and infectious diseases, both for research and clinical applications.

Entities:  

Mesh:

Year:  1999        PMID: 10318719

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  35 in total

1.  Role of diffusion-weighted MR imaging in cervical lymphadenopathy.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nermin Yehia Soliman; Sahar Elkhamary; Mousa K Alsharaway; Ali Tawfik
Journal:  Eur Radiol       Date:  2006-03-24       Impact factor: 5.315

Review 2.  Principles and implementation of diffusion-weighted and diffusion tensor imaging.

Authors:  Timothy P L Roberts; Erin Simon Schwartz
Journal:  Pediatr Radiol       Date:  2007-06-28

3.  Diffusion-weighted imaging can correctly identify false-positive lymph nodes on positron emission tomography in non-small cell lung cancer.

Authors:  Hiroaki Nomori; Yue Cong; Hiroshi Sugimura; Yoshiaki Kato
Journal:  Surg Today       Date:  2015-12-10       Impact factor: 2.549

4.  In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases.

Authors:  D Pal; A Bhattacharyya; M Husain; K N Prasad; C M Pandey; R K Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

5.  Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophrenia.

Authors:  Yukiko Saito; Marek Kubicki; Inga Koerte; Tatsui Otsuka; Yogesh Rathi; Ofer Pasternak; Sylvain Bouix; Ryan Eckbo; Zora Kikinis; Christian Clemm von Hohenberg; Tomohide Roppongi; Elisabetta Del Re; Takeshi Asami; Sang-Hyuk Lee; Sarina Karmacharya; Raquelle I Mesholam-Gately; Larry J Seidman; James Levitt; Robert W McCarley; Martha E Shenton; Margaret A Niznikiewicz
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

6.  A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer.

Authors:  Yoo Na Kim; Chin A Yi; Kyung Soo Lee; O Jung Kwon; Ho Yun Lee; Byung-Tae Kim; Joon Young Choi; Seon Woo Kim; Man Pyo Chung; Joungho Han; Tae Sung Kim; Myung Jin Chung; Young Mog Shim
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

7.  DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases.

Authors:  Terence M Williams; Stefanie Galbán; Fei Li; Kevin A Heist; Craig J Galbán; Theodore S Lawrence; Eric C Holland; Tami L Thomae; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

8.  Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability.

Authors:  M Wilson; C R Tench; P S Morgan; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging.

Authors:  Ping H Lai; Jih T Ho; Wei L Chen; Shu S Hsu; Jyh S Wang; Huay B Pan; Chien F Yang
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

10.  The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.

Authors:  Ramon F Barajas; Nicholas A Butowski; Joanna J Phillips; Manish K Aghi; Mitchel S Berger; Susan M Chang; Soonmee Cha
Journal:  Acad Radiol       Date:  2016-07-18       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.